A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
Public ClinicalTrials.gov record NCT04608500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-12)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.
Study identification
- NCT ID
- NCT04608500
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 771 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2017 (Actual)
- Primary completion
- Jul 2, 2018 (Actual)
- Completion
- Jul 31, 2018 (Actual)
- Last update posted
- Jan 7, 2021
2017 – 2018
United States locations
- U.S. sites
- 46
- U.S. states
- 20
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foamix Investigational Site # 207 | Glendale | Arizona | 85308 | — |
| Foamix Investigational Site # 202 | Hot Springs | Arkansas | 71913 | — |
| Foamix Investigational Site # 222 | Rogers | Arkansas | 72758 | — |
| Foamix Investigational Site #244 | Encino | California | 91436 | — |
| Foamix Investigational Site #249 | Huntington Beach | California | 92647 | — |
| Foamix Investigational Site # 226 | Los Angeles | California | 90045 | — |
| Foamix Investigational Site # 220 | Murrieta | California | 92562 | — |
| Foamix Investigational Site #251 | North Hollywood | California | 91606 | — |
| Foamix Investigational Site # 217 | San Diego | California | 92123 | — |
| Foamix Investigational Site #250 | San Marcos | California | 92078 | — |
| Foamix Investigational Site # 239 | Temecula | California | 92592 | — |
| Foamix Investigational Site # 227 | Denver | Colorado | 80209 | — |
| Foamix Investigational Site # 223 | Boca Raton | Florida | 33486 | — |
| Foamix Investigational Site # 215 | Boynton Beach | Florida | 33437 | — |
| Foamix Investigational Site #245 | DeLand | Florida | 32720 | — |
| Foamix Investigational Site # 240 | Fort Myers | Florida | 33912 | — |
| Foamix Investigational Site #247 | Hialeah | Florida | 33015 | — |
| Foamix Investigational Site #252 | Hialeah | Florida | 33106 | — |
| Foamix Investigational Site # 214 | Miami | Florida | 33126 | — |
| Foamix Investigational Site #246 | Miami | Florida | 33186 | — |
| Foamix Investigational Site # 241 | North Miami Beach | Florida | 33162 | — |
| Foamix Investigational Site #248 | Oldsmar | Florida | 34677 | — |
| Foamix Investigational Site # 204 | Newnan | Georgia | 78660 | — |
| Foamix Investigational Site # 211 | Arlington Heights | Illinois | 60005 | — |
| Foamix Investigational Site # 225 | Newburgh | Indiana | 47630 | — |
| Foamix Investigational Site #243 | Plainfield | Indiana | 46168 | — |
| Foamix Investigational Site # 218 | South Bend | Indiana | 46617 | — |
| Foamix Investigational Site # 235 | Louisville | Kentucky | 40217 | — |
| Foamix Investigational Site # 237 | Louisville | Kentucky | 40241 | — |
| Foamix Investigational Site # 229 | Watertown | Massachusetts | 02472 | — |
| Foamix Investigational Site # 210 | Detroit | Michigan | 48202 | — |
| Foamix Investigational Site # 232 | Fridley | Minnesota | 55432 | — |
| Foamix Investigational Site # 238 | High Point | North Carolina | 27262 | — |
| Foamix Investigational Site # 212 | Raleigh | North Carolina | 27612 | — |
| Foamix Investigational Site # 236 | Norman | Oklahoma | 73071 | — |
| Foamix Investigational Site # 224 | Exton | Pennsylvania | 19341 | — |
| Foamix Investigational Site # 230 | Mt. Pleasant | South Carolina | 29464 | — |
| Foamix Investigational Site # 228 | Knoxville | Tennessee | 37922 | — |
| Foamix Investigational Site # 219 | Arlington | Texas | 76011 | — |
| Foamix Investigational Site # 201 | Houston | Texas | 77004 | — |
| Foamix Investigational Site # 206 | Pflugerville | Texas | 78660 | — |
| Foamix Investigational Site # 208 | San Antonio | Texas | 78229 | — |
| Foamix Investigational Site # 213 | San Antonio | Texas | 78229 | — |
| Foamix Investigational Site # 209 | Webster | Texas | 77598 | — |
| Foamix Investigational Site # 216 | Lynchburg | Virginia | 24501 | — |
| Foamix Investigational Site # 203 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04608500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04608500 live on ClinicalTrials.gov.